These Factors Predict Shorter Time to PSA Failure : vimarsan

A new study identifies three factors associated with PSA failure in men with nonmetastatic unfavorable-risk prostate cancer, revealing who may benefit from treatment escalation.

Related Keywords

Dana Farber Cancer Institute , Massachusetts , United States , Boston , Martin Schoen , Mutlay Sayan , Charles Bennett , Prostate Carcinoma , Alignant Prostate Neoplasm , Prostate Cancer , Ancer Prostate , Cancer , Alignant Neoplasia , Arcinoma , Prostatic , Biologic Therapy , Prostate Specific Antigen Psa , Prostate Specific Antigen , Sa , Radiation Oncology , Antigens , Chemotherapy , Clinical Research , Clinical Trials , Linical Studies , Hospitals , Receptors , Healthcare And Medical Technology , Ealth And Medical Tech ,